Announcement on the Use of Self-owned Funds to Purchase Wealth Management Products
Chengdu Kanghong Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Kanghong Pharmaceutical" or "the Company") and all members of the Board of Directors guarantee that the content of the information disclosure is true, accurate, and complete, without false records, misleading statements, or major omissions.
The 18th meeting of the 8th Board of Directors and the 2025 Annual General Meeting of Shareholders of Chengdu Kanghong Pharmaceutical Group Co., Ltd. approved the proposal on the use of self-owned funds to purchase wealth management products. The Company and its subsidiaries are authorized to use part of the idle self-owned funds to purchase wealth management products (including structured deposits) within a limit not exceeding RMB 3.8 billion. The purchasing principle is to prioritize high safety, good liquidity, and short-term principal-protected wealth management products issued by commercial banks with a capital protection commitment. The purchase period is one year from the date of approval by the shareholders' meeting; within the above limit and period, funds can be used on a rolling basis. The Board of Directors authorized the president and financial officer of the Company to exercise specific purchasing decision-making rights based on the above principles, with the finance department responsible for the specific purchasing matters. Detailed information can be found in the Company's designated information disclosure media and the Giant Tide Information Network (www.cninfo.com.cn) published on April 24, 2026, in the "Resolution Announcement of the 18th Meeting of the 8th Board of Directors" (Announcement No. 2026-024), "Announcement on the Use of Self-owned Funds to Purchase Wealth Management Products" (Announcement No. 2026-026), and the "Resolution Announcement of the 2025 Annual General Meeting of Shareholders" (Announcement No. 2026-029).
Recently, the Company's subsidiary Sichuan Kanghong Pharmaceutical Trading Co., Ltd. (hereinafter referred to as "Sichuan Kangmao") used self-owned funds to purchase wealth management products. The relevant situation is announced as follows: